Literature DB >> 1965309

Growth factors specifically alter hair follicle cell proliferation and collagenolytic activity alone or in combination.

W C Weinberg1, P D Brown, W G Stetler-Stevenson, S H Yuspa.   

Abstract

A three-dimensional culture model for isolated murine pelage hair follicles in a type I collagen gel has been utilized to study the effects of selected growth factors on follicle cell proliferation and release of collagenolytic factors. Cultured follicle organoids differentially express cytokeratins 6 and 14 in a pattern suggesting they contain cells of the outer root sheath, inner root sheath and follicle matrix. Using incorporation of [3H]thymidine as a measure of proliferation, follicle organoids show a peak of DNA synthesis between day 1 and 5 of culture, depending on plating density, and then have a low rate of DNA synthesis. Thymidine incorporation is stimulated by transforming growth factor-alpha (TGF-alpha) in a dose-dependent response. Only peripheral cells presumably of the outer root sheath, incorporate thymidine in basal or stimulated conditions. TGF-beta 1 and TGF-beta 2 inhibit constitutive cell proliferation and oppose growth stimulation by TGF-alpha. Hair follicles lyse the collagen gel matrix when exposed to certain cytokines. Epidermal growth factor (EGF) and TGF-alpha stimulate gel lysis, but TGF-beta 1, TGF-beta 2 and cholera toxin do not. Other skin-derived cells, such as interfollicular epidermal cells, dermal fibroblasts, or combinations thereof, do not lyse gels in this culture model even when exposed to growth factors. Combinations of EGF or TGF-alpha with TGF-beta 1 or TGF-beta 2 are synergistic for collagenase release. These cytokines stimulate release of multiple species of matrix metalloproteinases, but the 92-kDa and 72 kDa type IV procollagenases and their activated derivatives predominate on zymograms. In cytokine-stimulated follicles, both peripheral and centrally located cells in the organoids express the 72-kDa type IV collagenase and a similar immunostaining pattern is present in developing follicles in vivo. Thus growth factors appear to work in concert for certain hair follicle responses and in opposition for others. These combined actions may play a role in different phases of hair follicle development that require cell replication and invasion into the deeper dermis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965309     DOI: 10.1111/j.1432-0436.1990.tb00470.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  13 in total

Review 1.  Protection against chemotherapy-induced alopecia.

Authors:  Jie Wang; Ze Lu; Jessie L-S Au
Journal:  Pharm Res       Date:  2006-11       Impact factor: 4.200

2.  Transforming growth factor alpha induces collagen degradation and cell migration in differentiating human epidermal raft cultures.

Authors:  K Turksen; Y Choi; E Fuchs
Journal:  Cell Regul       Date:  1991-08

3.  TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.

Authors:  S W Lin; M T Lee; F C Ke; P P Lee; C J Huang; M M Ip; L Chen; J J Hwang
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Matriptase expression and zymogen activation in human pilosebaceous unit.

Authors:  Bai-Yao Wu; Shiao-Pieng Lee; Hui-Chung Hsiao; Han Chiu; Chi-Yung Chen; Yee Hui Yeo; Herng-Sheng Lee; Ya-Wen Chen; Malvika Kaul; Hiroaki Kataoka; Michael D Johnson; Jehng-Kang Wang; Chen-Yong Lin
Journal:  J Histochem Cytochem       Date:  2013-09-04       Impact factor: 2.479

5.  An appraisal of laboratory models of androgenetic alopecia: A systematic review.

Authors:  S Ntshingila; N P Khumalo; M Engel; A T Arowolo
Journal:  Skin Health Dis       Date:  2021-03-05

6.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

Authors:  K Sellheyer; J R Bickenbach; J A Rothnagel; D Bundman; M A Longley; T Krieg; N S Roche; A B Roberts; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Interstitial collagenase gene expression in colonic neoplasia.

Authors:  S T Gray; K Yun; T Motoori; Y M Kuys
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

Review 8.  Matrix-degrading proteases in hormone-dependent breast cancer.

Authors:  R B Dickson; Y E Shi; M D Johnson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure.

Authors:  R Murillas; F Larcher; C J Conti; M Santos; A Ullrich; J L Jorcano
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

10.  Activity of type IV collagenases in benign and malignant breast disease.

Authors:  B Davies; D W Miles; L C Happerfield; M S Naylor; L G Bobrow; R D Rubens; F R Balkwill
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.